Researchers introduced a novel fluorescence imaging technique that can detect amyloids, key biomarkers in neurodegenerative diseases like Alzheimer's and Parkinson's, offering a simpler alternative to PET scans. This method utilizes a sensor array of coumarin-based molecular probes, capable of illuminating amyloids to monitor disease progression or distinguish between different conditions.
Researchers introduced a novel fluorescence imaging technique that can detect amyloids, key biomarkers in neurodegenerative diseases like Alzheimer's and Parkinson's, offering a simpler alternative to PET scans. This method utilizes a sensor array of coumarin-based molecular probes, capable of illuminating amyloids to monitor disease progression or distinguish between different conditions.
Share this Article
Recommended